Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle 
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation 
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026 
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China 
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support 
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market 
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025 
PURCHASE, NY, Oct. 17, 2017 -- Teladoc, Inc. (NYSE:TDOC), the world’s largest and most trusted telehealth provider, announced today that it will release third quarter 2017 results on Wednesday, November 1, 2017, after the market closes. In conjunction, the company will host a conference call to review results at 5 p.m. E.T. on the same day.
Conference Call Details
The conference call can be accessed by dialing 1-833-241-4255 for U.S. participants, or 1-647-689-4206 for international participants, and including the following Conference ID Number: 95641521 to expedite caller registration; additionally, access via a live audio webcast is available online at http://ir.teladoc.com/news-and-events/events-and-presentations/.
A replay will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will be available for approximately 90 days.
About Teladoc, Inc.
Teladoc, Inc. (NYSE:TDOC) is the largest and most trusted telehealth provider in the world. Recognized by MIT Technology Review as one of the “50 Smartest Companies”, Teladoc is forging a new healthcare experience with better convenience, outcomes and value. The company provides virtual access to high quality care and expertise, with a portfolio of services and solutions covering 450 medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. By marrying the latest in data and analytics with its award-winning user experience and highly flexible technology platform, Teladoc has delivered more than 2.5 million medical visits to patients around the globe. For additional information, please visit www.teladoc.com.
Media Contact:
Courtney McLeod
Director of Public Relations, Teladoc
914-265-6789
[email protected]
Investor Contacts:
Bob East
or
Asher Dewhurst
Westwicke Partners
443-213-0500
[email protected]
